Auburn, CANCT05058651Now EnrollingIRB Ready

Neuroendocrine Carcinoma Clinical Trial in Auburn, CA

Access cutting-edge neuroendocrine carcinoma treatment through this clinical trial at a research site in Auburn. Study-provided care at no cost to qualified participants.

Sponsored by National Cancer Institute (NCI)

Quick Self-Assessment

See if you qualify for this Auburn location

Preparing your pre-screening questions...

Expert Care in Auburn

Access neuroendocrine carcinoma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related neuroendocrine carcinoma treatment provided free

Apply for This Auburn Location

Check if you qualify for this neuroendocrine carcinoma clinical trial in Auburn, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Auburn

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Auburn site if eligible
  4. 4Begin participation

About This Neuroendocrine Carcinoma Study in Auburn

This phase II/III trial compares the effect of immunotherapy with atezolizumab in combination with standard chemotherapy with a platinum drug (cisplatin or carboplatin) and etoposide versus standard therapy alone for the treatment of poorly differentiated extrapulmonary (originated outside the lung) neuroendocrine cancer that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary s

Sponsor: National Cancer Institute (NCI)

Who Can Participate

Inclusion Criteria

Participants must have histologically-confirmed (local site pathological confirmation sufficient) extrapulmonary poorly differentiated, neuroendocrine carcinoma (NEC)
Participants must have disease that is unresectable or metastatic and not eligible for definitive therapy as deemed per the treating investigator
Participants must have radiologically evaluable disease, measurable or non-measurable, per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 criteria. All measurable and nonmeasurable lesions must be assessed by CT scan with IV contrast of the chest/abdomen/and pelvis (or CT chest without contrast and MRI abdomen/pelvis with gadolinium contrast, if contraindication to CT iodinated contrast) within 28 days prior to registration. While may be used for routine clinical evaluation, PET scans and bone scans alone are not acceptable for disease assessment while participating in this study. All known sites of disease must be assessed and documented on

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Auburn?

Yes, this clinical trial (NCT05058651) has an active research site in Auburn, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Neuroendocrine Carcinoma Treatment Options in Auburn, CA

If you're searching for neuroendocrine carcinoma treatment options in Auburn, CA, this clinical trial (NCT05058651) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Auburn research site is actively enrolling participants for this clinical trial. You'll receive care from experienced neuroendocrine carcinoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all neuroendocrine carcinoma clinical trials near you to find additional studies recruiting in your area.

More Neuroendocrine Tumors Trials in Auburn, CA

See all neuroendocrine tumors clinical trials recruiting in Auburn — not just this study.

Browse Neuroendocrine Tumors Trials in Auburn

Browse More Trials by Condition

Ready to Join in Auburn?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Auburn, CA